| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.557 | 10.262 | 14.246 | 6.475 | 12.897 | 13.117 | 26.174 | 19.376 | 22.047 | 12.779 |
| Total Income - EUR | 8.557 | 10.281 | 14.774 | 6.512 | 12.902 | 13.117 | 26.174 | 19.376 | 22.047 | 12.779 |
| Total Expenses - EUR | 7.278 | 8.290 | 10.799 | 8.867 | 10.122 | 9.869 | 11.100 | 8.752 | 8.534 | 7.637 |
| Gross Profit/Loss - EUR | 1.279 | 1.991 | 3.975 | -2.355 | 2.780 | 3.249 | 15.074 | 10.624 | 13.513 | 5.142 |
| Net Profit/Loss - EUR | 1.022 | 1.785 | 3.827 | -2.420 | 2.651 | 3.127 | 14.305 | 10.054 | 11.374 | 4.336 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Westrans Science S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.917 | 3.173 | 4.219 | 1.736 | 4.081 | 4.430 | 9.070 | 10.682 | 13.174 | 4.368 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.340 | 933 | 2.160 | 1.484 | 2.603 | 2.888 | 13 | 5 | 541 | 15 |
| Cash | 578 | 2.240 | 2.058 | 251 | 1.478 | 1.542 | 9.057 | 10.677 | 12.633 | 4.353 |
| Shareholders Funds | -19.091 | -17.111 | -12.994 | -15.175 | -12.230 | -8.871 | 5.630 | 10.114 | 11.433 | 4.395 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.008 | 20.284 | 17.212 | 16.911 | 16.312 | 13.302 | 3.440 | 569 | 1.752 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Westrans Science S.r.l.